Circulating nucleic acids in plasma and serum: Applications in diagnostic techniques for noninvasive prenatal diagnosis

International Journal of Women's Health

Volumn 5, Issue 1, 2013, Pages 177-186

  Gahan, Peter B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Amniotic fluid; Aneuploidy; Fetal circulating DNA RNA; Saliva; Thalassemias

Indexed keywords

CIRCULATING NUCLEIC ACID; DNA; NUCLEIC ACID; RHESUS D ANTIBODY; RNA; UNCLASSIFIED DRUG;

ACHONDROPLASIA; ALPHA THALASSEMIA; AMNION FLUID; ANEUPLOIDY; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA SEQUENCE; EARLY DIAGNOSIS; ERYTHROCYTE; FETUS; FETUS DEVELOPMENT; GENE MUTATION; GENE SEQUENCE; HEMOGLOBINOPATHY; HEMOPHILIA; HUMAN; HUNTINGTON CHOREA; MATERNAL BLOOD; MYOTONIC DYSTROPHY; NON INVASIVE PROCEDURE; PREECLAMPSIA; PREMATURITY; PRENATAL DIAGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SALIVA ANALYSIS; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; THALASSEMIA;

EID: 84876489948     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S34442     Document Type: Review

References (104)

1. Mendel P, Métais P. Les acides nucleiques du plasma sanguine chez l'homme. [Nucleic acids in human blood plasma]. C R Acad Sci Paris. 1948;142:241-243. French.
2. Watson JD, Crick FHC. A Structure for deoxyribose nucleic acid. Nature. 1953;171:737-738.
3. Wilkins MFH, Stokes AR, Wilson HR. Molecular structure of deoxypentose nucleic acids. Nature. 1953;171:738.
4. Sinsheimer RL. First Steps toward a genetic chemistry. Science. 1957;125:1123-1128.
5. Koffler D, Agnello V, Winchester R, et al. The occurrence of single stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest. 1973;52:198-204.
6. Leon SA, Shapiro B, Sklaroff D, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37:646-650.
7. Stroun M, Anker P, Maurice P, et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology. 1989;46:318-712.
8. Gahan PB, Stroun M. The biology of circulating nucleic acids in plasma and serum. In: Rykova EY, Kikuchi Y, editors. Extracellular Nucleic Acids. In NAMB series "Nucleic Acids and Molecular Biology". Berlin: Springer; 2010.
9. Wataganara T, LeShane ES, Chen AY, et al. Plasma gamma-globulin gene expression suggest that fetal hemapoietic cells contribute to the pool of circulating cell-free fetal nucleic acids during pregnancy. Clin Chem. 2004;50:689.
10. Wataganara T, Leshane ES, Chen AY, et al. Circulating cell-free fetal nucleic acids may be a model marker of fetomaternal hemorrhage after elective first = trimester termination of pregnancy. Ann N Y Acad Sci. 2004;1022:129-134.
11. Lo YMD. Towards the development of noninvasive prenatal diagnosis of fetal chromosomal aneuploidies. Ann N Y Acad Sci. 2008;1137:140-143.
12. Bianchi DW, Leshane ES, Cowan JM. Large amounts of cell-free fetal DNA are present in amniotic fluid. Clin Chem. 2001;47: 1867-1869.
13. Chan KCA, Zhang J, Hui ABY, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem. 2004;50:88-92.
14. Li Y, Zimmermann B, Rusterholz B, et al. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem. 2004;50:1002-1011.
15. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007;110:1459-1467.
16. Odeh M, Granin V, Kais M, et al. Sonographic fetal sex determination. Obstet Gynecol Surv. 2009;64:50-57.
17. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485-487.
18. Walknowska J, Conte FA, Grumbach MM. Practical and theoretical implications of fetal/maternal lymphocyte transfer. Lancet. 1969;1:1119-1122.
19. Lo YMD, Patel P, Wainscoat JS, et al. Prenatal sex determination by DNA amplification from maternal peripheral blood. Lancet. 1989;2:1363-1365.
20. Cha DH, Khosrotehrani K, Bianchi DW, et al. The utility of an erythroblast scoring system and gender-independent short tandem repeat (STR) analysis for the detection of aneuploid fetal cells in maternal blood. Prenat Diagn. 2005;25:586-591.
21. Bianchi DW. Fetal cells in the maternal circulation: feasibility for prenatal diagnosis [Review]. Br J Haematol. 1999;105:574-583.
22. Bianchi DW, Simpson JL, Jackson LG, et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analyses of NIFTY I data. Prenatal Diag. 2002;22:609-615.
23. Smid M, Lagona F, de Benassuti L, et al. Evaluation of different approaches for fetal DNA analysis from maternal plasma and nucleated blood cells. Clin Chem. 1999;45:1570-1572.
24. Houfflin-Debarge V, O'Donnell H, Overton T, et al. High sensitivity of fetal DNA in plasma compared to serum and nucleated cells using unnested PCR in maternal blood. Fetal Diagn Ther. 2000;15: 102-107.
25. Lo YMD, Tein MSC, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62:768-775.
26. Lo YM, Zhang J, Leung TN, et al. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999;64:218-224.
27. Tsui NBY, Jiang P, Chow KCK, et al. High resolution size analysis of fetal DNA in the urine of pregnant women by paired-end massively parallel sequencing. PLoS One. 2012;7:e48319.
28. Korbel JO, Urban AE, Affourtit JP, et al. Paired-end mapping reveals extensive structural variation in the human genome. Science. 2007;318:420-426.
29. Kidd JM, Cooper GM, Donahue WF, et al. Mapping and sequencing of structural variation from eight human genomes. Nature. 2008;453:56-64.
30. Levy S, Sutton G, Ng PC, et al. The diploid genome sequence of an individual human. PLoS Biol. 2007;5:e254.
31. Wang J, Wang W, Li R, et al. The diploid genome sequence of an Asian individual. Nature. 2008;456:60-65.
32. Lo YMD, Chiu RWK. Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications. J Path. 2011;25:318-323.
33. Lo YMD, Chan KCA, Sun H, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010;2:61ra91.
34. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A. 2008;105:16266-16271.
35. Fan C, Gu W, Wang J, et al. Non-invasive prenatal measurement of the fetal genome. Nature. Epub August 18, 2012.
36. Hui L, Bianchi DW. Cell-free fetal nucleic acids in amniotic fluid. Hum Reprod Update. 2011;17:362-371.
37. Larrabee PB, Johnson KL, Pestova E, et al. Microarray analysis of cell-free fetal DNA in amniotic fluid: a prenatal molecular karyotype. Am J Hum Genet. 2004;75:485-491.
38. Miura S, Miura K, Masuzaki H, et al. Microarray comparative genomic hybridization (CGH)-based prenatal diagnosis for chromosome abnormalities using cell-free fetal DNA in amniotic fluid. J Hum Genet. 2006;51:412-417.
39. Poon LLM, Leung TN, Lau TK, et al. Presence of fetal RNA in maternal plasma. Clin Chem. 2000;46:1832-1834.
40. Ng EK, Tsui NB, Lau TK, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A. 2003;100:4748-4753.
41. Reddi KK, Holland JF. Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci U S A. 1976;73:2308-2310.
42. Gahan PB, Stroun M. The virtosome a novel cytosolic informative entity and intracellular messenger. Cell Biochem Funct. 2010;28:529-538.
43. Ng EK, Leung TN, Tsui NB, et al. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem. 2003;49:727-731.
44. Go AT, Visser A, Mulders MA, et al. Detection of placental transcription factor mRNA in maternal plasma. Clin Chem. 2004;50: 1413-1414.
45. Larrabee PB, Johnson KL, Lai C, et al. Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. J Am Med Assoc. 2005;293:836-842.
46. Slonim DK, Koide K, Johnson KL, et al. Functional genomic analysis of amniotic fluid cell-free mRNA implies that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci U S A. 2009;106:9425-9429.
47. Hui L, Slonim DK, Wick HC, et al. The amniotic fluid transcriptome: a source of novel information about human fetal development. Obstet Gynecol. 2012;119:111-118.
48. Maron JL, Johnson KL, Rocke DM, et al. Neonatal salivary analysis reveals global developmental gene expression: changes in the premature infant. Clin Chem. 2010;56:409-416.
49. Vainer OB, Katokhin AV, Khustov SM, et al. A new Y chromosome marker for non-invasive fetal gender determination. Ann N Y Acad Sci. 2008;1137:157-161.
50. Vecchione G, Tomaiuolo M, Sarno M, et al. Fetal identification in maternal plasma by means of short tandem repeats on chromosome X. Ann N Y Acad Sci. 2008;1137:148-156.
51. Wright CF, Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update. 2009;15:139-151.
52. Tang NLS, Leung TN, Zhang J, et al. Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma. Clin Chem. 1999;45:2033-2035.
53. Chen C-P, Chern S-R, Wang W. Fetal DNA analyzed in plasma from a mother's three consecutive pregnancies to detect paternally inherited aneuploidy. Clin Chem. 2001;47:937-939.
54. Ghorbian S. Applications of cell free fetal DNA in maternal serum. Int J Fertility Fetal Med. 2012;3:33-39.
55. Lo YM, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med. 1998;339:1734-1738.
56. Bischoff FZ, Nguyen DD, Marquéz-Do D, et al. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Investig. 1999;6:64-69.
57. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci. 2004;1022:119-124.
58. Daniels G, Finning K, Martin P, et al. Fetal blood group genotyping. Present and future. Ann N Y Acad Sci. 2006;1075:88-95.
59. Finning K, Martin P, Summers J, et al. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ. 2008;336:816-826.
60. Cardo L, Garcia BP, Alvarez FV. Non-invasive fetal RDH genotyping in the first trimester of pregnancy. Clin Chem Lab Med. 2010;48: 1121-1126.
61. Sedrak L M, Hashad D, Adel H, et al. Use of free fetal DNA in prenatal noninvasive detection of fetal RhD status and fetal gender by molecular analysis of maternal plasma. Genet Test Mol Biomarkers. 2011;15:627-631.
62. Bombard AT, Akolekar R, Farkas DH, et al. Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in nonsensitised RhD negative women. Prenat Diagn. 2011;31:802-828.
63. Akolekar R, Farkas DH, VanAgtmael AL, et al. Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation. Prenat Diagn. 2010;30:918-923.
64. Kotzol D, Bundscherer G, Bernasconi F, et al. Isochromosome 18P results from maternal meiosis-II nondisjunction. Eur J Hum Genet. 1996;4:168-174.
65. Yang YH, Kim IK, Oh SH, et al. Rapid prenatal diagnosis of trisomy 21 by polymerase chain reaction associated analysis of small tandem repeats and S100B in chromosome 21. Fetal Diagn Ther. 1998;13:361-366.
66. Yang YH, Nam MS, Yang ES. Rapid prenatal diagnosis of trisomy 21 by real-time quantitative polymerase chain reaction with amplification of small tandem repeats and S100B in chromosome 21. Yonsei Med J. 2005;46:193-197.
67. Lo YMD, Chiu RWK. Noninvasive prenatal diagnosis of fetal chromosome aneuploidies by maternal plasma nucleic analysis. Clin Chem. 2008;54:461-466.
68. Go AT, van Vugt JM, Oudejans CB. Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities. Hum Reprod Update. 2011;17:372-382.
69. Papageorgiou EA, Fiegler H, Rakyan V, et al. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol. 2009;174:1609-1618.
70. Papageorgiou EA, Karagrigoriou A, Tsaliki E, et al. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med. 2011;17:510-513.
71. Chiu RWK, Akolakar R, Zheng YWL, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ. 2011;342:c7401.
72. Ehrich M, Dsciu C, Zwieelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol. 2011;204:205-208.
73. Bianchi DW, Platt LD, Goldberg JD, et al; MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012;119:890-901.
74. Canick JA, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn. 2012;32:730-734.
75. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med. 2011;13:913-920.
76. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med. 2012;14:296-305.
77. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012;207:137. e1-e8.
78. Sparks A, Wang E, Struble C, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn. 2012;32:1-7.
79. Sparks AB, Struble CA, Wang E, et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012;206:319. e1-e9.
80. Chiu RW, Lau TK, Leung TN, et al. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet. 2002;360:998-1000.
81. Papasavva T, Kalikas I, Kyrri A, et al. Noninvasive prenatal diagnostic assay for the detection of β-thalassemia. Ann N Y Acad Sci. 2006;107:148-153.
82. Papasavva T, Kalikas I, Kyrri A, et al. Arrayed primer extension for the noninvasive prenatal diagnosis of β-thalassemia based on detection of single nucleotide polymorphisms. Ann N Y Acad Sci. 2008;1137:302-330.
83. Papassava T, van Eicken W, Kockx C, et al. High throughput sequencing enables non-invasive prenatal diagnosis of beta thalassemia using SNPs. J Nucleic Acids Invest. 2011;2:5-6.
84. 0-thalassemia in maternal plasma. PLoS One. 2011;6:e24779.
85. Ho SS, Chong SS, Koay ES, et al. Microsatellite markers within -SEA breakpoints for prenatal diagnosis of HbBarts hydrops fetalis. Clin Chem. 2007;53:173-179.
86. Ho SS, Chong SS, Koay ES, et al. Noninvasive prenatal exclusion of haemoglobin Bart's using foetal DNA from maternal plasma. Prenat Diagn. 2010;30:65-73.
87. Li Y, Page-Christiaens CG, Gille JJ, et al. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDITOF MS assay. Prenat Diagn. 2007;27:11-17.
88. Lim JHL, Kim MJ, Kim SY, et al. Non-invasive prenatal detection of achondroplasia using circulating fetal DNA in maternal plasma. J Assist Reprod Genet. 2011;28:167-172.
89. González-González MC, Garcia-Hoyos M, Trujillo MJ, et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diag. 2002;22:946-948.
90. Tsui NBY, Kadir RA, Chan KCA, et al. PCR analysis of maternal plasma DNA Noninvasive prenatal diagnosis of hemophilia. Blood. 2011;117:3684-3691.
91. González-González MC, Garcia-Hoyos M, Trujillo-Tiebas MJ, et al. Improvement in strategies for the non-invasive prenatal diagnosis of Huntington disease. J Assist Reprod Genet. 2008;25:477-481.
92. Amicucci P, Gennarelli M, Novelli G, et al. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem. 2000;46:301-302.
93. Bonifazi E, Gullotta F, Vallo L, et al. Use of RNA fluorescence in situ hybridization in the prenatal molecular diagnosis of myotonic dystrophy type I. Clin Chem. 2006;52:319-322.
94. Barrett AN, McDonnell TCR, Chan KCA, et al. Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clin Chem. 2012;58:1026-1032.
95. Sifakis S, Zaravinos A, Maiz N, et al. First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol. 2009;201:472. e1-e7.
96. Swaminathan R, Butt A. Circulating nucleic acids in plasma and serum: recent developments. Ann N Y Acad Sci. 2006;1075:1-9.
97. Chim SS, Tong YK, Chiu RW, et al. Detection of the epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A. 2005;102:14753-14758.
98. Wong BC, Chiu RW, Tsui NB, et al. Circulating placental RNA in maternal plasma is associated with a preponderance of 5′ mRNA fragments: implications for non-invasive prenatal diagnosis and monitoring. Clin Chem. 2005;51:1786-1795.
99. Lázár L, Nagy B, Morvarec A, et al. The correlation of circulating cell-free DNA, cell-free fetal DNA and microRNA 325 levels to clinical characteristics and laboratory parameters in pre-eclampsia. In: Gahan PB, editor. Circulating Nucleic Acids in Plasma and Serum. Berlin: Springer; 2010:155-158.
100. Deans Z, Hill M, Chitty LS, et al. Non-invasive prenatal testing for single gene disorders: exploring the ethics. Eur J Hum Genet. Epub November 28, 2012.
101. Legler TJ, Mavrou A, Finning K, et al. Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn. 2007;27:824-829.
102. EuroGentest [homepage on the Internet]. Available from: http://www.eurogentest.org. Accessed March 19, 2013.
103. RAPID [homepage on the Internet]. Available from: http://www.rapid.nhs.uk. Accessed March 19, 2013.
104. UK NEQAS [homepage on the Internet]. Available from: http://www.ukneqas.org.uk. Accessed March 19, 2013.